Utility of measuring (1,3)-β-d-glucan in cerebrospinal fluid for diagnosis of fungal central nervous system infection

J Clin Microbiol. 2015 Jan;53(1):319-22. doi: 10.1128/JCM.02301-14. Epub 2014 Nov 5.

Abstract

(1-3)-β-d-Glucan (BDG) from cerebrospinal fluid (CSF) is a promising marker for diagnostic and prognostic aid of central nervous system (CNS) fungal infection, but its relationship to serum values has not been studied. Herein, we detected BDG from CSF at levels 2-fold lower than those in serum in patients without evidence of fungal disease but 25-fold higher than those in in serum in noncryptococcal CNS fungal infections. CSF BDG may be a useful biomarker in the evaluation of fungal CNS disease.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers / cerebrospinal fluid*
  • Central Nervous System Fungal Infections / cerebrospinal fluid*
  • Central Nervous System Fungal Infections / diagnosis*
  • Central Nervous System Fungal Infections / epidemiology*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Proteoglycans
  • Young Adult
  • beta-Glucans / cerebrospinal fluid*

Substances

  • Biomarkers
  • Proteoglycans
  • beta-Glucans
  • polysaccharide-K